Investing.com – Biogen (NASDAQ:) reported on Tuesday first quarter that missed analysts’ forecasts and income that topped expectations.
Biogen introduced earnings per share of $3.62 on income of $2.53B. Analysts polled by Investing.com anticipated EPS of $4.34 on income of $2.5B.
Biogen shares are up 6.49% from the start of the 12 months, nonetheless down 55.72% from its 52 week excessive of $468.20 set on June 7, 2021. They’re outperforming the which is down 19.88% from the beginning of the 12 months.
Biogen follows different main Healthcare sector earnings this month
Biogen’s report follows an earnings beat by UnitedHealth on April 14, who reported EPS of $5.49 on income of $80.15B, in comparison with forecasts EPS of $5.36 on income of $78.73B.
J&J had beat expectations on April 19 with first quarter EPS of $2.67 on income of $23.43B, in comparison with forecast for EPS of $2.59 on income of $23.62B.
Keep up-to-date on all the upcoming earnings stories by visiting Investing.com’s earnings calendar